These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 24033786)
1. Targeted hepatitis C screening among ex-injection drug users in the community. Wong VW; Wong GL; Chim AM; Cheng TF; Cheung SW; Lai CM; Szeto KJ; Tsang S; Wu SH; Yan KK; Hui AY; Yiu DC; Wu BB; Cheung D; Chung CS; Lai CW; Chan HL J Gastroenterol Hepatol; 2014 Jan; 29(1):116-20. PubMed ID: 24033786 [TBL] [Abstract][Full Text] [Related]
2. Point-of-care testing for HCV infection: recent advances and implications for alternative screening. Parisi MR; Soldini L; Vidoni G; Mabellini C; Belloni T; Brignolo L; Negri S; Schlusnus K; Dorigatti F; Lazzarin A New Microbiol; 2014 Oct; 37(4):449-57. PubMed ID: 25387283 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users. Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710 [TBL] [Abstract][Full Text] [Related]
4. Acute hepatitis C: prevention and treatment. Ozaras R; Tahan V Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247 [TBL] [Abstract][Full Text] [Related]
5. Outcome of screening for hepatitis C virus infection based on risk factors. Mallette C; Flynn MA; Promrat K Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related]
7. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731 [TBL] [Abstract][Full Text] [Related]
9. Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece. Papadopoulos N; Manolakopoulos S; Deutsch M; Mela M; Christidou A; Katoglou A; Tzourmakliotis D; Papatheodoridis GV Eur J Gastroenterol Hepatol; 2013 May; 25(5):587-93. PubMed ID: 23426269 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy. Hallinan R; Byrne A; Amin J; Dore GJ J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218 [TBL] [Abstract][Full Text] [Related]
11. Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre. Islam MM; Topp L; Conigrave KM; White A; Reid SE; Grummett S; Haber PS; Day CA J Subst Abuse Treat; 2012 Dec; 43(4):440-5. PubMed ID: 22938915 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea. Kwon SY; Ahn MS; Chang HJ J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222 [TBL] [Abstract][Full Text] [Related]
13. [Community-based screening: a motivating experience for drug users]. Grammatico-Guillon L; Arnault É; Rollier S; Bonnemaison G; Dubois F; Rusch E Sante Publique; 2015; 27(5):633-9. PubMed ID: 26752029 [TBL] [Abstract][Full Text] [Related]
14. FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study. Foucher J; Reiller B; Jullien V; Léal F; di Cesare ES; Merrouche W; Delile JM; de Lédinghen V J Viral Hepat; 2009 Feb; 16(2):121-31. PubMed ID: 19175876 [TBL] [Abstract][Full Text] [Related]
15. Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France. Sahajian F; Vanhems P; Bailly F; Fabry J; Trepo C; Sepetjan M Eur J Public Health; 2007 Jun; 17(3):263-71. PubMed ID: 17068003 [TBL] [Abstract][Full Text] [Related]
16. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a general practice based hepatitis C virus screening intervention. Anderson EM; Mandeville RP; Hutchinson SJ; Cameron SO; Mills PR; Fox R; Ahmed S; Taylor A; Spence E; Goldberg DJ Scott Med J; 2009 Aug; 54(3):3-7. PubMed ID: 19728405 [TBL] [Abstract][Full Text] [Related]
18. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3. Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772 [TBL] [Abstract][Full Text] [Related]